Revenue for the quarter under review increased by 18% to RM930.56 million compared to RM785.36 million previously.

“This was largely contributed by the increase in bed occupancy rate (BOR) from higher patient visits and bed capacity in the current quarter,” it said in a filing with Bursa Malaysia.

The specialist healthcare provider said the Malaysia segment accounted for approximately 98% of its total revenue at RM914.2 million in Q2 2024, representing a 19% increase from RM770.5 million recorded in Q2 2023.

KPJ Healthcare also declared a single-tier interim dividend of one sen per share, payable on Oct 4.

In the first half of 2024 (H1 2024), the group’s net profit improved by 49.9% to RM147.27 million from RM98.27 million in H1 2023.

Revenue increased by 15% to RM1.84 billion from RM1.6 billion previously.

On prospects, KPJ Healthcare said the group continues to embark on its strategic initiatives, including assets optimisation, bed expansion and talent acquisition.

“The group continues to face a competitive talent landscape in the healthcare industry, while cost pressures are expected to remain in the near future.

“We are cautiously optimistic on our prospects for the current financial year ending Dec 31,” it said.

At the close of trading, KPJ Healthcare’s share price was down by three sen or 1.6% at RM1.85, giving the group a market capitalisation of RM8.37 billion.